Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2021

01-12-2021 | Magnetic Resonance Imaging | Research article

Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study

Authors: Nicole Rübsamen, Aleksandra Maceski, David Leppert, Pascal Benkert, Jens Kuhle, Heinz Wiendl, Annette Peters, André Karch, Klaus Berger

Published in: BMC Medicine | Issue 1/2021

Login to get access

Abstract

Background

Neurofilament light chain (NfL) is a cytoskeletal protein component whose release into blood is indicative of neuronal damage. Tau is a microtubule-associated protein in neurons and strongly associated with overall brain degeneration. NfL and tau levels are associated with mortality in different neurological diseases, but studies in the general population are missing. We investigated whether NfL and tau serum levels could serve as prognostic markers for overall mortality in elderly individuals without pre-defined neurological conditions. Further, we investigated the cross-sectional associations between NfL, tau, neuropsychological functioning, and brain structures.

Methods

In 1997, 385 inhabitants of Augsburg who were aged 65 years and older were included in the Memory and Morbidity in Augsburg Elderly (MEMO) study. They participated in a face-to-face medical interview including neuropsychological tests and magnetic resonance imaging (MRI) of the brain. NfL and tau were measured from non-fasting blood samples using highly sensitive single molecule array assays. To assess the prognostic accuracy of the biomarkers, concordance statistics based on the predicted 5-year survival probabilities were calculated for different Cox regression models. Associations between the biomarkers and the neuropsychological test scores or brain structures were investigated using linear or logistic regression.

Results

NfL (HR 1.27, 95% CI [1.14–1.42]) and tau (1.20 [1.07–1.35]) serum levels were independently associated with all-cause mortality. NfL, but not tau, increased the prognostic accuracy when added to a model containing sociodemographic characteristics (concordance statistic 0.684 [0.612–0.755] vs. 0.663 [0.593–0.733]), but not when added to a model containing sociodemographic characteristics and brain atrophy or neuropsychological test scores. NfL serum levels were cross-sectionally associated with neuropsychological test scores and brain structures.

Conclusions

The association between NfL serum levels and brain atrophy and neuropsychological performance in individuals without overt neurological disease is similar to that seen in patients with neurodegenerative diseases. These findings support the concept of a continuum of physiological aging and incipient, subclinical pathology, and manifest disease.
NfL, but not tau, serum levels might serve as a prognostic marker for all-cause mortality if no other clinical information is available.
Appendix
Available only for authorised users
Literature
1.
Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14:577–89.PubMedCrossRef
2.
Constantinescu R, Rosengren L, Eriksson B, Blennow K, Axelsson M. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Acta Neurol Scand. 2019;140:147–56.PubMedCrossRef
3.
Sofou K, Shahim P, Tulinius M, Blennow K, Zetterberg H, Mattsson N, et al. Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients. Mitochondrion. 2019;46:228–35.PubMedCrossRef
4.
Skillbäck T, Farahmand B, Bartlett JW, Rosén C, Mattsson N, Nägga K, et al. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology. 2014;83:1945–53.PubMedCrossRef
5.
Skillbäck T, Mattsson N, Blennow K, Zetterberg H. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:397–403.PubMedCrossRef
6.
Staffaroni AM, Kramer AO, Casey M, Kang H, Rojas JC, Orrú CD, et al. Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease. JAMA Neurol. 2019;76:969.PubMedCentralCrossRefPubMed
7.
Uphaus T, Bittner S, Gröschel S, Steffen F, Muthuraman M, Wasser K, et al. NfL (neurofilament light chain) levels as a predictive marker for long-term outcome after ischemic stroke. Stroke. 2019;50:3077–84.PubMedCrossRef
8.
Hviid CVB, Gyldenholm T, Lauridsen SV, Hjort N, Hvas A-M, Parkner T. Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage. Clin Chem Lab Med. 2020;58:261–7.
9.
10.
Yu W-H, Wang W-H, Dong X-Q, Du Q, Yang D-B, Shen Y-F, et al. Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta. 2014;433:174–8.PubMedCrossRef
11.
Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54:1655–61.
12.
Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11:1–9.CrossRef
13.
de Wolf F, Ghanbari M, Licher S, McRae-McKee K, Gras L, Weverling GJ, et al. Plasma tau, neurofilament light chain and amyloid-b levels and risk of dementia; a population-based cohort study. Brain. 2020;143:1220–32.PubMedPubMedCentralCrossRef
14.
Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Vemuri P, Skoog I, et al. Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures. Neurology. 2019;93:E252–60.PubMedPubMedCentralCrossRef
15.
Schmidt W-P, Roesler A, Kretzschmar K, Ladwig K-H, Junker R, Berger K. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc. 2004;52:1045–50.PubMedCrossRef
16.
Keil U, Liese AD, Hense HW, Filipiak B, Döring A, Stieber J, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Disease. Eur Heart J. 1998;19:1197–207.PubMedCrossRef
17.
Nilsson L-G, Söderlund H, Berger K, Breteler M, de Ridder M, Dufouil C, et al. Cognitive test battery of CASCADE: tasks and data. Aging Neuropsychol Cogn. 2005;12:32–56.CrossRef
18.
Nilsson L-G, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. The Betula prospective cohort study: memory, health, and aging. Aging Neuropsychol Cogn. 1997;4:1–32.CrossRef
19.
Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–62.CrossRef
20.
Salthouse T. The role of memory in the age decline in digit-symbol substitution performance. J Gerontol. 1978;33:232–8.PubMedCrossRef
21.
Costa LD, Vaughn HG, Levita E, Farber N. Perdue Pegboard as a predictor of the presence and laterality of cerebral lesions. J Consult Psychol. 1963;27:133–7.PubMedCrossRef
22.
Achten E, Breteler M, de Leeuw FE. Rating scale for age related brain changes. Imaging Decis MRI. 2000;4:10–9.
23.
de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70:9–14.PubMedPubMedCentralCrossRef
24.
Delcoigne B, Manouchehrinia A, Barro C, Benkert P, Michalak Z, Kappos L, et al. Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology. 2020;94:e1201–12.PubMedPubMedCentralCrossRef
25.
Shahim P, Tegner Y, Wilson DH, Randall J, Skillbäck T, Pazooki D, et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014;71:684.PubMedCrossRef
26.
Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343–6.PubMedCrossRef
27.
Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964–74.PubMedCrossRef
28.
Figueiras A, Domenech-Massons JM, Cadarso C. Regression models: calculating the confidence interval of effects in the presence of interactions. Stat Med. 1998;17:2099–105.PubMedCrossRef
29.
van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.CrossRef
30.
31.
Miles A. Obtaining predictions from models fit to multiply imputed data. Sociol Methods Res. 2016;45:175–85.CrossRef
32.
White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29:2920–31.PubMedCrossRef
33.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128–38.PubMedPubMedCentralCrossRef
34.
Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35:1925–31.PubMedPubMedCentralCrossRef
35.
Antolini L, Nam B-H, D’Agostino RB. Inference on correlated discrimination measures in survival analysis: a nonparametric approach. Commun Stat - Theory Methods. 2004;33:2117–35.CrossRef
36.
Saarela O, Havulinna AS. validstats: various prediction model validation statistics. R package version 1.4; 2017.
37.
Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–16.PubMedPubMedCentralCrossRef
38.
Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol. 2019;48:1294–304.PubMedPubMedCentralCrossRef
39.
Harrell FE. {rms}: regression modeling strategies. R package version 5.1-3.1; 2019.
40.
Kotrlik J, Williams H, Jabor MK. Reporting and interpreting effect size in quantitative agricultural education research. J Agric Educ. 2011;52:132–42.CrossRef
41.
42.
Moore EE, Hohman TJ, Badami FS, Pechman KR, Osborn KE, Acosta LMY, et al. Neurofilament relates to white matter microstructure in older adults. Neurobiol Aging. 2018;70:233–41.PubMedPubMedCentralCrossRef
43.
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, et al. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain. 2018;141:2382–91.PubMedCrossRef
44.
Mariotto S, Farinazzo A, Magliozzi R, Alberti D, Monaco S, Ferrari S. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies. J Peripher Nerv Syst. 2018;23:174–7.PubMedCrossRef
45.
Lehmann HC, Wunderlich G, Fink GR, Sommer C. Diagnosis of peripheral neuropathy. Neurol Res Pract. 2020;2:20.
Metadata
Title
Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study
Authors
Nicole Rübsamen
Aleksandra Maceski
David Leppert
Pascal Benkert
Jens Kuhle
Heinz Wiendl
Annette Peters
André Karch
Klaus Berger
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-021-01915-8

Other articles of this Issue 1/2021

BMC Medicine 1/2021 Go to the issue

Research article

Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study

Research article

Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses

Research article

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

Research article

A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies

Research article

Using Mendelian randomization study to assess the renal effects of antihypertensive drugs

Research article

A better understanding of the association between maternal perception of foetal movements and late stillbirth—findings from an individual participant data meta-analysis